Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-β signaling

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Seo, Ji Hae ^a,b   Maki, Takakuni ^a   Maeda, Mitsuyo ^c,d   Miyamoto, Nobukazu ^a   Liang, Anna C ^a   Hayakawa, Kazuhide ^a   Pham, Loc Duyen D ^a   Suwa, Fumihiko ^c   Taguchi, Akihiko ^d   Matsuyama, Tomohiro ^e   Ihara, Masafumi ^f   Kim, Kyu Won ^b,g   Lo, Eng H ^a   Arai, Ken ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Seoul National University   (South Korea)

^c OSAKA DENTAL UNIVERSITY   (Japan)

^d INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

^f NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^g Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN HEMORRHAGE; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; PERICYTE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; CYTOLOGY; METABOLISM; NEURAL STEM CELL; OLIGODENDROGLIA; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; NEURAL STEM CELLS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84905388735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103174     Document Type: Article

References (46)

1. Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4: 399-415. (Pubitemid 37280178)
2. Ronaldson PT, Davis TP (2012) Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr Pharm Des 18: 3624-3644.
3. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
4. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41-53. (Pubitemid 41828930)
5. Winkler EA, Bell RD, Zlokovic BV (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14: 1398-1405.
6. Quaegebeur A, Lange C, Carmeliet P (2011) The neurovascular link in health and disease: molecular mechanisms and therapeutic implications. Neuron 71: 406-424.
7. Obermeier B, Daneman R, Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19: 1584-1596.
8. Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468: 562-566.
9. Dohgu S, Takata F, Yamauchi A, Nakagawa S, Egawa T, et al. (2005) Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res 1038: 208-215. (Pubitemid 40332685)
10. Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, et al. (2010) Pericytes regulate the blood-brain barrier. Nature 468: 557-561.
11. Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, et al. (2003) SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 9: 900-906. (Pubitemid 36889933)
12. Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, et al. (2011) The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334: 1727-1731.
13. Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M (2011) Apolipoprotein E regulates the integrity of tight junctions in an isoformdependent manner in an in vitro blood-brain barrier model. J Biol Chem 286: 17536-17542.
14. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485: 512-516.
15. Seo JH, Miyamoto N, Hayakawa K, Pham LD, Maki T, et al. (2013) Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. J Clin Invest 123: 782-786.
16. Arai K, Lo E (2009) An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. The Journal of neuroscience: the official journal of the Society for Neuroscience 29: 4351-4356.
17. Pallast S, Arai K, Wang X, Lo E, van Leyen K (2009) 12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress. Journal of neurochemistry 111: 882-891.
18. Hayakawa K, Seo JH, Pham LD, Miyamoto N, Som AT, et al. (2012) Cerebral endothelial derived vascular endothelial growth factor promotes the migration but not the proliferation of oligodendrocyte precursor cells in vitro. Neurosci Lett 513: 42-46.
19. Pham LD, Hayakawa K, Seo JH, Nguyen MN, Som AT, et al. (2012) Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia 60: 875-881.
20. Miyamoto N, Pham LD, Seo JH, Kim KW, Lo EH, et al. (2014) Crosstalk between cerebral endothelium and oligodendrocyte. Cell Mol Life Sci 71: 1055-1066.
21. ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8: 857-869.
22. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, et al. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121: 1845-1854.
23. Larsson J, Goumans MJ, Sjostrand LJ, van Rooijen MA, Ward D, et al. (2001) Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J 20: 1663-1673. (Pubitemid 32299403)
24. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, et al. (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21: 1743-1753. (Pubitemid 34614630)
25. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA (1989) An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A 86: 4544-4548. (Pubitemid 19164588)
26. Garcia CM, Darland DC, Massingham LJ, D'Amore PA (2004) Endothelial cell-astrocyte interactions and TGF beta are required for induction of blood-neural barrier properties. Brain Res Dev Brain Res 152: 25-38. (Pubitemid 38993285)
27. Hansson E, Ronnback L (2003) Glial neuronal signaling in the central nervous system. FASEB J 17: 341-348. (Pubitemid 36292950)
28. Wilkins A, Majed H, Layfield R, Compston A, Chandran S (2003) Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 23: 4967-4974. (Pubitemid 36793223)
29. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, et al. (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487: 443-448.
30. Arai K, Jin G, Navaratna D, Lo E (2009) Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. The FEBS journal 276: 4644-4696.
31. Lo EH (2008) A new penumbra: transitioning from injury into repair after stroke. Nat Med 14: 497-500.
32. Maki T, Hayakawa K, Pham LD, Xing C, Lo EH, et al. (2013) Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases. CNS Neurol Disord Drug Targets 12: 302-315.
33. Carmichael ST (2010) Targets for neural repair therapies after stroke. Stroke 41: S124-126.
34. Ohab JJ, Fleming S, Blesch A, Carmichael ST (2006) A neurovascular niche for neurogenesis after stroke. J Neurosci 26: 13007-13016. (Pubitemid 44954619)
35. Madri JA (2009) Modeling the neurovascular niche: implications for recovery from CNS injury. J Physiol Pharmacol 60 Suppl 4: 95-104.
36. Arai K, Lo E (2009) Oligovascular signaling in white matter stroke. Biological & pharmaceutical bulletin 32: 1639-1683.
37. Manole MD, Tehranian-DePasquale R, Du L, Bayir H, Kochanek PM, et al. (2011) Unmasking sex-based disparity in neuronal metabolism. Curr Pharm Des 17: 3854-3860.
38. Du L, Hickey RW, Bayir H, Watkins SC, Tyurin VA, et al. (2009) Starving neurons show sex difference in autophagy. J Biol Chem 284: 2383-2396.
39. Du L, Bayir H, Lai Y, Zhang X, Kochanek PM, et al. (2004) Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem 279: 38563-38570. (Pubitemid 39296010)
40. Levine JM, Reynolds R, Fawcett JW (2001) The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24: 39-47. (Pubitemid 32332895)
41. Zhang R, Chopp M, Zhang ZG (2013) Oligodendrogenesis after cerebral ischemia. Front Cell Neurosci 7: 201.
42. Maki T, Liang AC, Miyamoto N, Lo EH, Arai K (2013) Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases. Front Cell Neurosci 7: 275.
43. Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198.
44. Yang Y, Rosenberg GA (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42: 3323-3328.
45. Nishiyama A, Komitova M, Suzuki R, Zhu X (2009) Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 10: 9-22.
46. Polito A, Reynolds R (2005) NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat 207: 707-716. (Pubitemid 43019730)